CIPROFLOXACIN News

CIPROFLOXACIN currently has 8 news articles, with 45 predicted indications.

This page combines the AI-predicted indications for CIPROFLOXACIN with the latest health news. Indications highlighted in orange have recent news coverage.

Drug Information

Evidence level: L5
Predicted indications (45):
- infectious diarrheal disease (99.0%)
- prostatitis (disease) (99.0%)
- streptococcal pneumonia (99.0%)
- salmonellosis (99.0%)
- rhinoscleroma (99.0%)
- anthrax infection (99.0%)
- streptococcal infection (99.0%)
- otitis externa (99.0%)
- arthropathy (99.0%)
- chancroid (99.0%)
- acute contagious conjunctivitis (99.0%)
- dysentery (99.0%)
- conjunctivitis (99.0%)
- bacterial arthritis (99.0%)
- cystitis (99.0%)
- malignant otitis externa caused by Pseudomonas aeruginosa (99.0%)
- maxillary sinusitis (99.0%)
- shigellosis (99.0%)
- external ear disease (99.0%)
- lymphogranuloma venereum (99.0%)
- paratyphoid fever (99.0%)
- acute gonococcal cervicitis (99.0%)
- botulism (99.0%)
- staphylococcal infection (99.0%)
- staphylococcus aureus infection (99.0%)
- escherichia coli infection (99.0%)
- bacterial pneumonia (99.0%)
- trigonitis (99.0%)
- necrotizing ulcerative gingivitis (99.0%)
- typhoid fever (99.0%)
- intestinal infectious disease (99.0%)
- leptospirosis (99.0%)
- Pseudomonas aeruginosa infectious disease (99.0%)
- diarrheal disease (99.0%)
- yaws (99.0%)
- diffuse scleroderma (99.9%)
- hyperamylasemia (99.9%)
- polyclonal hyperviscosity syndrome (99.9%)
- congenital analbuminemia (99.8%)
- blood group incompatibility (99.8%)
- premalignant hematological system disease (99.7%)
- punctate epithelial keratoconjunctivitis (99.7%)
- monoclonal gammopathy (99.7%)
- hematological disease associated with an acquired peripheral neuropathy (99.7%)
- septicemic plague (99.6%)